Profund Advisors LLC Summit Therapeutics Inc. Transaction History
Profund Advisors LLC
- $2.67 Billion
- Q4 2024
A detailed history of Profund Advisors LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 59,277 shares of SMMT stock, worth $1.05 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
59,277
Previous 22,319
165.59%
Holding current value
$1.05 Million
Previous $488,000
116.8%
% of portfolio
0.04%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$434 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$208 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$140 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$117 Million0.01% of portfolio
-
State Street Corp Boston, MA5.6MShares$99.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.58B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...